CRL News and Press, Charles River Laboratories International Inc. From 04/29/24

2024-04-29 13:17:15 ET More on S&P 500 Index: Soft Landing On Track, With New All-Time Highs Ahead Yen Dumps Before It Jumps S&P 500: Trade Of The Year. Week Starting 29th April (Technical Analysis) Nasdaq, S&P, and Dow rise with the latest Fed de...

2024-04-29 08:47:01 ET More on Iterum Therapeutics Iterum Therapeutics plc (ITRM) Q4 2023 Earnings Call Transcript Iterum Therapeutics Non-GAAP EPS of -$0.81 Iterum spikes on accelerated timeline for FDA filing Seeking Alpha’s Quant Rating on Iterum Th...

2024-04-28 15:24:54 ET Marathon Petroleum ( MPC ), 63 Coterra Energy ( CTRA ), 60 Info Tech... Read the full article on Seeking Alpha For further details see: With rate cuts pushed out, Goldman looks at quality stocks

2024-04-25 17:01:08 ET Summary Danaher Corporation stock has surged by 16% since our "Strong Buy" rating in June 2023, outperforming the S&P 500. The bioprocessing industry is facing near-term challenges, but long-term growth prospects remain strong. Danaher's Q1 FY24 resu...

Company marks significant progress towards climate goals, reaching the milestone considerably ahead of schedule Charles River Laboratories International, Inc. (NYSE: CRL) today announced it has reached 100 percent renewable electricity across all of its global sites as of the first quar...

2024-04-18 13:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Initiative focuses on innovation, partnerships, and advocacy as part of $500 million investment in driving change Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it is launching its Alternative Methods Advancement Project (AMAP), an initiative dedicated t...

Charles River Laboratories International, Inc. (NYSE: CRL) will release first-quarter 2024 financial results on Thursday, May 9 th , before the market opens. A conference call has been scheduled to discuss this information on Thursday, May 9 th , at 8:30 a.m. ET. Investors will have t...

Powered by digital pathology and AI algorithms, Patholytix Foresight drives speed and quality in toxicologic pathology practices Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of Patholytix Foresight, a non-clinical artificial intelligence (AI)...

2024-04-09 10:48:26 ET More on Charles River Laboratories Charles River Laboratories: Weak Biopharma Spending Is Transitory; Initiate With 'Hold' Charles River Laboratories International, Inc. (CRL) Q4 2023 Earnings Call Transcript Charles River brokers gene therapy ...